Ebola Vaccine Reaches Trials Just 68 Days After Outbreak

Scientists fast-tracked a Bundibugyo Ebola vaccine from freezer to human trials in just over two months, using lessons learned from COVID-19.

With 620,000 doses already manufactured, researchers aim to begin outbreak trials in Uganda by late 2026.